Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Express Scripts
Citi
UBS
Baxter
Queensland Health
Teva
Mallinckrodt

Generated: April 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: empagliflozin

« Back to Dashboard

empagliflozin

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Boehringer Ingelheim JARDIANCE empagliflozin TABLET;ORAL 204629 NDA Boehringer Ingelheim Pharmaceuticals, Inc. N 0597-0152-70
Boehringer Ingelheim JARDIANCE empagliflozin TABLET;ORAL 204629 NDA Boehringer Ingelheim Pharmaceuticals, Inc. N 0597-0152-37
Boehringer Ingelheim JARDIANCE empagliflozin TABLET;ORAL 204629 NDA Boehringer Ingelheim Pharmaceuticals, Inc. N 0597-0152-30
Boehringer Ingelheim JARDIANCE empagliflozin TABLET;ORAL 204629 NDA Boehringer Ingelheim Pharmaceuticals, Inc. N 0597-0152-90
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Boehringer Ingelheim
Argus Health
Johnson and Johnson
Deloitte
Colorcon
McKinsey
Farmers Insurance